What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 5 minute read Healthcare Industry News Medline’s $6.26bn IPO marks turning point for medical supply sector capital flows Medline raised $6.26B in 2025’s biggest IPO, aiming to cut debt and expand operations. Find out what this means for investors, rivals, and the IPO market. byPallavi MadhirajuDecember 17, 2025